Global Primary Immunodeficiency Drugs Production, Demand and Key Producers, 2022-2028
Drugs for the treatment of primary immunodeficiency diseases
This report studies the global Primary Immunodeficiency Drugs production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Primary Immunodeficiency Drugs, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Primary Immunodeficiency Drugs that contribute to its increasing demand across many markets.
The global Primary Immunodeficiency Drugs market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global Primary Immunodeficiency Drugs total production and demand, 2017-2028, (K Units)
Global Primary Immunodeficiency Drugs total production value, 2017-2028, (USD Million)
Global Primary Immunodeficiency Drugs production by region & country, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Primary Immunodeficiency Drugs consumption by region & country, CAGR, 2017-2028 & (K Units)
U.S. VS China: Primary Immunodeficiency Drugs domestic production, consumption, key domestic manufacturers and share
Global Primary Immunodeficiency Drugs production by manufacturer, production, price, value and market share 2017-2022, (USD Million) & (K Units)
Global Primary Immunodeficiency Drugs production by Type, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Primary Immunodeficiency Drugs production by Application production, value, CAGR, 2017-2028, (USD Million) & (K Units)
This reports profiles key players in the global Primary Immunodeficiency Drugs market based on the following parameters – headquarters, production locations, products portfolio, Primary Immunodeficiency Drugs revenue, sales, average price and gross margin, recent developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Primary Immunodeficiency Drugs market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global Primary Immunodeficiency Drugs Market, By Region:
1. How big is the global Primary Immunodeficiency Drugs market?
2. What is the demand of the global Primary Immunodeficiency Drugs market?
3. What is the year over year growth of the global Primary Immunodeficiency Drugs market?
4. What is the production and production value of the global Primary Immunodeficiency Drugs market?
5. Who are the key producers in the global Primary Immunodeficiency Drugs market?
6. What are the growth factors driving the market demand?
This report studies the global Primary Immunodeficiency Drugs production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Primary Immunodeficiency Drugs, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Primary Immunodeficiency Drugs that contribute to its increasing demand across many markets.
The global Primary Immunodeficiency Drugs market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global Primary Immunodeficiency Drugs total production and demand, 2017-2028, (K Units)
Global Primary Immunodeficiency Drugs total production value, 2017-2028, (USD Million)
Global Primary Immunodeficiency Drugs production by region & country, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Primary Immunodeficiency Drugs consumption by region & country, CAGR, 2017-2028 & (K Units)
U.S. VS China: Primary Immunodeficiency Drugs domestic production, consumption, key domestic manufacturers and share
Global Primary Immunodeficiency Drugs production by manufacturer, production, price, value and market share 2017-2022, (USD Million) & (K Units)
Global Primary Immunodeficiency Drugs production by Type, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Primary Immunodeficiency Drugs production by Application production, value, CAGR, 2017-2028, (USD Million) & (K Units)
This reports profiles key players in the global Primary Immunodeficiency Drugs market based on the following parameters – headquarters, production locations, products portfolio, Primary Immunodeficiency Drugs revenue, sales, average price and gross margin, recent developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Primary Immunodeficiency Drugs market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global Primary Immunodeficiency Drugs Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Cytokines
- Anti Cytokine Antibodies
- Signal Molecule Inhibitor
- Hospital
- Specialist Clinic
- Othere
- ADMA Biologics, Inc.
- CSL Behring, LLC
- Octapharma
- Takeda Pharmaceutical Company
- Grifols Biologicals, Inc.
- Baxter
- Kedrion Biopharma
- BPL Inc.
- Pharming Group
- Shire
- Chengdu Rongsheng Pharmaceutical Co., Ltd
1. How big is the global Primary Immunodeficiency Drugs market?
2. What is the demand of the global Primary Immunodeficiency Drugs market?
3. What is the year over year growth of the global Primary Immunodeficiency Drugs market?
4. What is the production and production value of the global Primary Immunodeficiency Drugs market?
5. Who are the key producers in the global Primary Immunodeficiency Drugs market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Primary Immunodeficiency Drugs Introduction
1.2 World Primary Immunodeficiency Drugs Supply & Forecast
1.2.1 World Primary Immunodeficiency Drugs Production Value (2017 & 2021 & 2028)
1.2.2 World Primary Immunodeficiency Drugs Production (2017-2028)
1.2.3 World Primary Immunodeficiency Drugs Pricing Trends (2017-2028)
1.3 World Primary Immunodeficiency Drugs Production by Region
1.3.1 World Primary Immunodeficiency Drugs Production Value by Region (2017-2028)
1.3.2 World Primary Immunodeficiency Drugs Production by Region (2017-2028)
1.3.3 World Primary Immunodeficiency Drugs Average Price by Region (2017-2028)
1.3.4 North America Primary Immunodeficiency Drugs Production (2017-2028)
1.3.5 Europe Primary Immunodeficiency Drugs Production (2017-2028)
1.3.6 China Primary Immunodeficiency Drugs Production (2017-2028)
1.3.7 Japan Primary Immunodeficiency Drugs Production (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 Primary Immunodeficiency Drugs Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Primary Immunodeficiency Drugs Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Primary Immunodeficiency Drugs Demand (2017-2028)
2.2 World Primary Immunodeficiency Drugs Consumption by Region
2.2.1 World Primary Immunodeficiency Drugs Consumption by Region (2017-2022)
2.2.2 World Primary Immunodeficiency Drugs Consumption Forecast by Region (2023-2028)
2.3 United States Primary Immunodeficiency Drugs Consumption (2017-2028)
2.4 China Primary Immunodeficiency Drugs Consumption (2017-2028)
2.5 Europe Primary Immunodeficiency Drugs Consumption (2017-2028)
2.6 Japan Primary Immunodeficiency Drugs Consumption (2017-2028)
2.7 South Korea Primary Immunodeficiency Drugs Consumption (2017-2028)
2.8 ASEAN Primary Immunodeficiency Drugs Consumption (2017-2028)
2.9 India Primary Immunodeficiency Drugs Consumption (2017-2028)
3 WORLD PRIMARY IMMUNODEFICIENCY DRUGS MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Primary Immunodeficiency Drugs Production Value by Manufacturer (2017-2022)
3.2 World Primary Immunodeficiency Drugs Production by Manufacturer (2017-2022)
3.3 World Primary Immunodeficiency Drugs Average Price by Manufacturer (2017-2022)
3.4 Primary Immunodeficiency Drugs Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Primary Immunodeficiency Drugs Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Primary Immunodeficiency Drugs in 2021
3.5.3 Global Concentration Ratios (CR8) for Primary Immunodeficiency Drugs in 2021
3.6 Primary Immunodeficiency Drugs Market: Overall Company Footprint Analysis
3.6.1 Primary Immunodeficiency Drugs Market: Region Footprint
3.6.2 Primary Immunodeficiency Drugs Market: Company Product Type Footprint
3.6.3 Primary Immunodeficiency Drugs Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Primary Immunodeficiency Drugs Production Value Comparison
4.1.1 United States VS China: Primary Immunodeficiency Drugs Production Value Comparison (2017 & 2021 & 2028)
4.1.2 United States VS China: Primary Immunodeficiency Drugs Production Value Market Share Comparison (2017 & 2021 & 2028)
4.2 United States VS China: Primary Immunodeficiency Drugs Production Comparison
4.2.1 United States VS China: Primary Immunodeficiency Drugs Production Comparison (2017 & 2021 & 2028)
4.2.2 United States VS China: Primary Immunodeficiency Drugs Production Market Share Comparison (2017 & 2021 & 2028)
4.3 United States VS China: Primary Immunodeficiency Drugs Consumption Comparison
4.3.1 United States VS China: Primary Immunodeficiency Drugs Consumption Comparison (2017 & 2021 & 2028)
4.3.2 United States VS China: Primary Immunodeficiency Drugs Consumption Market Share Comparison (2017 & 2021 & 2028)
4.4 United States Primary Immunodeficiency Drugs Key Producers and Market Share, 2017-2022
4.4.1 Major Manufacturer of Primary Immunodeficiency Drugs in United States, Company Headquarters and Production Place (States, Country)
4.4.2 United States Primary Immunodeficiency Drugs Production Value by Domestic Manufacturer, (2017-2022)
4.4.3 United States Primary Immunodeficiency Drugs Production by Domestic Manufacturer, (2017-2022)
4.5 China Primary Immunodeficiency Drugs Key Producers and Market Share, 2017-2022
4.5.1 Major Manufacturer of Primary Immunodeficiency Drugs in China, Company Headquarters and Production Place (Province, Country)
4.5.2 China Primary Immunodeficiency Drugs Production Value by Domestic Manufacturer, (2017-2022)
4.5.3 China Primary Immunodeficiency Drugs Production by Domestic Manufacturer, (2017-2022)
4.6 Rest of World Primary Immunodeficiency Drugs Key Producers and Market Share, 2017-2022
4.6.1 Major Manufacturer of Primary Immunodeficiency Drugs in Rest of World, Company Headquarters and Production Place (State, Country)
4.6.2 Rest of World Primary Immunodeficiency Drugs Production Value by Domestic Manufacturer, (2017-2022)
4.6.3 Rest of World Primary Immunodeficiency Drugs Production by Domestic Manufacturer, (2017-2022)
5 MARKET ANALYSIS BY TYPE
5.1 World Primary Immunodeficiency Drugs Market Size Overview by Type: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Type
5.2.1 Cytokines
5.2.2 Anti Cytokine Antibodies
5.2.3 Signal Molecule Inhibitor
5.3 Market Segment by Type
5.3.1 World Primary Immunodeficiency Drugs Production by Type (2017-2028)
5.3.2 World Primary Immunodeficiency Drugs Production Value by Type (2017-2028)
5.3.3 World Primary Immunodeficiency Drugs Average Price by Type (2017-2028)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Primary Immunodeficiency Drugs Market Size Overview by Application: 2017 VS 2021 VS 2028
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Specialist Clinic
6.2.3 Othere
6.3 Market Segment by Application
6.3.1 World Primary Immunodeficiency Drugs Production by Application (2017-2028)
6.3.2 World Primary Immunodeficiency Drugs Production Value by Application (2017-2028)
6.3.3 World Primary Immunodeficiency Drugs Average Price by Application (2017-2028)
7 COMPANY PROFILES
7.1 ADMA Biologics, Inc.
7.1.1 ADMA Biologics, Inc. Details
7.1.2 ADMA Biologics, Inc. Major Business
7.1.3 ADMA Biologics, Inc. Primary Immunodeficiency Drugs Product and Services
7.1.4 ADMA Biologics, Inc. Primary Immunodeficiency Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.1.5 ADMA Biologics, Inc. Recent Developments/Updates
7.1.6 ADMA Biologics, Inc. Competitive Strengths & Weaknesses
7.2 CSL Behring, LLC
7.2.1 CSL Behring, LLC Details
7.2.2 CSL Behring, LLC Major Business
7.2.3 CSL Behring, LLC Primary Immunodeficiency Drugs Product and Services
7.2.4 CSL Behring, LLC Primary Immunodeficiency Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.2.5 CSL Behring, LLC Recent Developments/Updates
7.2.6 CSL Behring, LLC Competitive Strengths & Weaknesses
7.3 Octapharma
7.3.1 Octapharma Details
7.3.2 Octapharma Major Business
7.3.3 Octapharma Primary Immunodeficiency Drugs Product and Services
7.3.4 Octapharma Primary Immunodeficiency Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.3.5 Octapharma Recent Developments/Updates
7.3.6 Octapharma Competitive Strengths & Weaknesses
7.4 Takeda Pharmaceutical Company
7.4.1 Takeda Pharmaceutical Company Details
7.4.2 Takeda Pharmaceutical Company Major Business
7.4.3 Takeda Pharmaceutical Company Primary Immunodeficiency Drugs Product and Services
7.4.4 Takeda Pharmaceutical Company Primary Immunodeficiency Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.4.5 Takeda Pharmaceutical Company Recent Developments/Updates
7.4.6 Takeda Pharmaceutical Company Competitive Strengths & Weaknesses
7.5 Grifols Biologicals, Inc.
7.5.1 Grifols Biologicals, Inc. Details
7.5.2 Grifols Biologicals, Inc. Major Business
7.5.3 Grifols Biologicals, Inc. Primary Immunodeficiency Drugs Product and Services
7.5.4 Grifols Biologicals, Inc. Primary Immunodeficiency Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.5.5 Grifols Biologicals, Inc. Recent Developments/Updates
7.5.6 Grifols Biologicals, Inc. Competitive Strengths & Weaknesses
7.6 Baxter
7.6.1 Baxter Details
7.6.2 Baxter Major Business
7.6.3 Baxter Primary Immunodeficiency Drugs Product and Services
7.6.4 Baxter Primary Immunodeficiency Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.6.5 Baxter Recent Developments/Updates
7.6.6 Baxter Competitive Strengths & Weaknesses
7.7 Kedrion Biopharma
7.7.1 Kedrion Biopharma Details
7.7.2 Kedrion Biopharma Major Business
7.7.3 Kedrion Biopharma Primary Immunodeficiency Drugs Product and Services
7.7.4 Kedrion Biopharma Primary Immunodeficiency Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.7.5 Kedrion Biopharma Recent Developments/Updates
7.7.6 Kedrion Biopharma Competitive Strengths & Weaknesses
7.8 BPL Inc.
7.8.1 BPL Inc. Details
7.8.2 BPL Inc. Major Business
7.8.3 BPL Inc. Primary Immunodeficiency Drugs Product and Services
7.8.4 BPL Inc. Primary Immunodeficiency Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.8.5 BPL Inc. Recent Developments/Updates
7.8.6 BPL Inc. Competitive Strengths & Weaknesses
7.9 Pharming Group
7.9.1 Pharming Group Details
7.9.2 Pharming Group Major Business
7.9.3 Pharming Group Primary Immunodeficiency Drugs Product and Services
7.9.4 Pharming Group Primary Immunodeficiency Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.9.5 Pharming Group Recent Developments/Updates
7.9.6 Pharming Group Competitive Strengths & Weaknesses
7.10 Shire
7.10.1 Shire Details
7.10.2 Shire Major Business
7.10.3 Shire Primary Immunodeficiency Drugs Product and Services
7.10.4 Shire Primary Immunodeficiency Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.10.5 Shire Recent Developments/Updates
7.10.6 Shire Competitive Strengths & Weaknesses
7.11 Chengdu Rongsheng Pharmaceutical Co., Ltd
7.11.1 Chengdu Rongsheng Pharmaceutical Co., Ltd Details
7.11.2 Chengdu Rongsheng Pharmaceutical Co., Ltd Major Business
7.11.3 Chengdu Rongsheng Pharmaceutical Co., Ltd Primary Immunodeficiency Drugs Product and Services
7.11.4 Chengdu Rongsheng Pharmaceutical Co., Ltd Primary Immunodeficiency Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.11.5 Chengdu Rongsheng Pharmaceutical Co., Ltd Recent Developments/Updates
7.11.6 Chengdu Rongsheng Pharmaceutical Co., Ltd Competitive Strengths & Weaknesses
8 RAW MATERIAL AND INDUSTRY CHAIN
8.1 Raw Material of Primary Immunodeficiency Drugs and Key Manufacturers
8.2 Primary Immunodeficiency Drugs Manufacturing Costs
8.3 Primary Immunodeficiency Drugs Production Process
8.4 Primary Immunodeficiency Drugs Industrial Chain
9 DISTRIBUTION CHANNEL ANALYSIS
9.1 Distribution Channel Breakdown for Primary Immunodeficiency Drugs Shipments (%): 2017-2028
9.1.1 Direct Channel
9.1.2 Indirect Channel
9.2 Primary Immunodeficiency Drugs Typical Distributors
9.3 Primary Immunodeficiency Drugs Typical Customers
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
1.1 Primary Immunodeficiency Drugs Introduction
1.2 World Primary Immunodeficiency Drugs Supply & Forecast
1.2.1 World Primary Immunodeficiency Drugs Production Value (2017 & 2021 & 2028)
1.2.2 World Primary Immunodeficiency Drugs Production (2017-2028)
1.2.3 World Primary Immunodeficiency Drugs Pricing Trends (2017-2028)
1.3 World Primary Immunodeficiency Drugs Production by Region
1.3.1 World Primary Immunodeficiency Drugs Production Value by Region (2017-2028)
1.3.2 World Primary Immunodeficiency Drugs Production by Region (2017-2028)
1.3.3 World Primary Immunodeficiency Drugs Average Price by Region (2017-2028)
1.3.4 North America Primary Immunodeficiency Drugs Production (2017-2028)
1.3.5 Europe Primary Immunodeficiency Drugs Production (2017-2028)
1.3.6 China Primary Immunodeficiency Drugs Production (2017-2028)
1.3.7 Japan Primary Immunodeficiency Drugs Production (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 Primary Immunodeficiency Drugs Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Primary Immunodeficiency Drugs Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Primary Immunodeficiency Drugs Demand (2017-2028)
2.2 World Primary Immunodeficiency Drugs Consumption by Region
2.2.1 World Primary Immunodeficiency Drugs Consumption by Region (2017-2022)
2.2.2 World Primary Immunodeficiency Drugs Consumption Forecast by Region (2023-2028)
2.3 United States Primary Immunodeficiency Drugs Consumption (2017-2028)
2.4 China Primary Immunodeficiency Drugs Consumption (2017-2028)
2.5 Europe Primary Immunodeficiency Drugs Consumption (2017-2028)
2.6 Japan Primary Immunodeficiency Drugs Consumption (2017-2028)
2.7 South Korea Primary Immunodeficiency Drugs Consumption (2017-2028)
2.8 ASEAN Primary Immunodeficiency Drugs Consumption (2017-2028)
2.9 India Primary Immunodeficiency Drugs Consumption (2017-2028)
3 WORLD PRIMARY IMMUNODEFICIENCY DRUGS MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Primary Immunodeficiency Drugs Production Value by Manufacturer (2017-2022)
3.2 World Primary Immunodeficiency Drugs Production by Manufacturer (2017-2022)
3.3 World Primary Immunodeficiency Drugs Average Price by Manufacturer (2017-2022)
3.4 Primary Immunodeficiency Drugs Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Primary Immunodeficiency Drugs Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Primary Immunodeficiency Drugs in 2021
3.5.3 Global Concentration Ratios (CR8) for Primary Immunodeficiency Drugs in 2021
3.6 Primary Immunodeficiency Drugs Market: Overall Company Footprint Analysis
3.6.1 Primary Immunodeficiency Drugs Market: Region Footprint
3.6.2 Primary Immunodeficiency Drugs Market: Company Product Type Footprint
3.6.3 Primary Immunodeficiency Drugs Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Primary Immunodeficiency Drugs Production Value Comparison
4.1.1 United States VS China: Primary Immunodeficiency Drugs Production Value Comparison (2017 & 2021 & 2028)
4.1.2 United States VS China: Primary Immunodeficiency Drugs Production Value Market Share Comparison (2017 & 2021 & 2028)
4.2 United States VS China: Primary Immunodeficiency Drugs Production Comparison
4.2.1 United States VS China: Primary Immunodeficiency Drugs Production Comparison (2017 & 2021 & 2028)
4.2.2 United States VS China: Primary Immunodeficiency Drugs Production Market Share Comparison (2017 & 2021 & 2028)
4.3 United States VS China: Primary Immunodeficiency Drugs Consumption Comparison
4.3.1 United States VS China: Primary Immunodeficiency Drugs Consumption Comparison (2017 & 2021 & 2028)
4.3.2 United States VS China: Primary Immunodeficiency Drugs Consumption Market Share Comparison (2017 & 2021 & 2028)
4.4 United States Primary Immunodeficiency Drugs Key Producers and Market Share, 2017-2022
4.4.1 Major Manufacturer of Primary Immunodeficiency Drugs in United States, Company Headquarters and Production Place (States, Country)
4.4.2 United States Primary Immunodeficiency Drugs Production Value by Domestic Manufacturer, (2017-2022)
4.4.3 United States Primary Immunodeficiency Drugs Production by Domestic Manufacturer, (2017-2022)
4.5 China Primary Immunodeficiency Drugs Key Producers and Market Share, 2017-2022
4.5.1 Major Manufacturer of Primary Immunodeficiency Drugs in China, Company Headquarters and Production Place (Province, Country)
4.5.2 China Primary Immunodeficiency Drugs Production Value by Domestic Manufacturer, (2017-2022)
4.5.3 China Primary Immunodeficiency Drugs Production by Domestic Manufacturer, (2017-2022)
4.6 Rest of World Primary Immunodeficiency Drugs Key Producers and Market Share, 2017-2022
4.6.1 Major Manufacturer of Primary Immunodeficiency Drugs in Rest of World, Company Headquarters and Production Place (State, Country)
4.6.2 Rest of World Primary Immunodeficiency Drugs Production Value by Domestic Manufacturer, (2017-2022)
4.6.3 Rest of World Primary Immunodeficiency Drugs Production by Domestic Manufacturer, (2017-2022)
5 MARKET ANALYSIS BY TYPE
5.1 World Primary Immunodeficiency Drugs Market Size Overview by Type: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Type
5.2.1 Cytokines
5.2.2 Anti Cytokine Antibodies
5.2.3 Signal Molecule Inhibitor
5.3 Market Segment by Type
5.3.1 World Primary Immunodeficiency Drugs Production by Type (2017-2028)
5.3.2 World Primary Immunodeficiency Drugs Production Value by Type (2017-2028)
5.3.3 World Primary Immunodeficiency Drugs Average Price by Type (2017-2028)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Primary Immunodeficiency Drugs Market Size Overview by Application: 2017 VS 2021 VS 2028
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Specialist Clinic
6.2.3 Othere
6.3 Market Segment by Application
6.3.1 World Primary Immunodeficiency Drugs Production by Application (2017-2028)
6.3.2 World Primary Immunodeficiency Drugs Production Value by Application (2017-2028)
6.3.3 World Primary Immunodeficiency Drugs Average Price by Application (2017-2028)
7 COMPANY PROFILES
7.1 ADMA Biologics, Inc.
7.1.1 ADMA Biologics, Inc. Details
7.1.2 ADMA Biologics, Inc. Major Business
7.1.3 ADMA Biologics, Inc. Primary Immunodeficiency Drugs Product and Services
7.1.4 ADMA Biologics, Inc. Primary Immunodeficiency Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.1.5 ADMA Biologics, Inc. Recent Developments/Updates
7.1.6 ADMA Biologics, Inc. Competitive Strengths & Weaknesses
7.2 CSL Behring, LLC
7.2.1 CSL Behring, LLC Details
7.2.2 CSL Behring, LLC Major Business
7.2.3 CSL Behring, LLC Primary Immunodeficiency Drugs Product and Services
7.2.4 CSL Behring, LLC Primary Immunodeficiency Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.2.5 CSL Behring, LLC Recent Developments/Updates
7.2.6 CSL Behring, LLC Competitive Strengths & Weaknesses
7.3 Octapharma
7.3.1 Octapharma Details
7.3.2 Octapharma Major Business
7.3.3 Octapharma Primary Immunodeficiency Drugs Product and Services
7.3.4 Octapharma Primary Immunodeficiency Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.3.5 Octapharma Recent Developments/Updates
7.3.6 Octapharma Competitive Strengths & Weaknesses
7.4 Takeda Pharmaceutical Company
7.4.1 Takeda Pharmaceutical Company Details
7.4.2 Takeda Pharmaceutical Company Major Business
7.4.3 Takeda Pharmaceutical Company Primary Immunodeficiency Drugs Product and Services
7.4.4 Takeda Pharmaceutical Company Primary Immunodeficiency Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.4.5 Takeda Pharmaceutical Company Recent Developments/Updates
7.4.6 Takeda Pharmaceutical Company Competitive Strengths & Weaknesses
7.5 Grifols Biologicals, Inc.
7.5.1 Grifols Biologicals, Inc. Details
7.5.2 Grifols Biologicals, Inc. Major Business
7.5.3 Grifols Biologicals, Inc. Primary Immunodeficiency Drugs Product and Services
7.5.4 Grifols Biologicals, Inc. Primary Immunodeficiency Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.5.5 Grifols Biologicals, Inc. Recent Developments/Updates
7.5.6 Grifols Biologicals, Inc. Competitive Strengths & Weaknesses
7.6 Baxter
7.6.1 Baxter Details
7.6.2 Baxter Major Business
7.6.3 Baxter Primary Immunodeficiency Drugs Product and Services
7.6.4 Baxter Primary Immunodeficiency Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.6.5 Baxter Recent Developments/Updates
7.6.6 Baxter Competitive Strengths & Weaknesses
7.7 Kedrion Biopharma
7.7.1 Kedrion Biopharma Details
7.7.2 Kedrion Biopharma Major Business
7.7.3 Kedrion Biopharma Primary Immunodeficiency Drugs Product and Services
7.7.4 Kedrion Biopharma Primary Immunodeficiency Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.7.5 Kedrion Biopharma Recent Developments/Updates
7.7.6 Kedrion Biopharma Competitive Strengths & Weaknesses
7.8 BPL Inc.
7.8.1 BPL Inc. Details
7.8.2 BPL Inc. Major Business
7.8.3 BPL Inc. Primary Immunodeficiency Drugs Product and Services
7.8.4 BPL Inc. Primary Immunodeficiency Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.8.5 BPL Inc. Recent Developments/Updates
7.8.6 BPL Inc. Competitive Strengths & Weaknesses
7.9 Pharming Group
7.9.1 Pharming Group Details
7.9.2 Pharming Group Major Business
7.9.3 Pharming Group Primary Immunodeficiency Drugs Product and Services
7.9.4 Pharming Group Primary Immunodeficiency Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.9.5 Pharming Group Recent Developments/Updates
7.9.6 Pharming Group Competitive Strengths & Weaknesses
7.10 Shire
7.10.1 Shire Details
7.10.2 Shire Major Business
7.10.3 Shire Primary Immunodeficiency Drugs Product and Services
7.10.4 Shire Primary Immunodeficiency Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.10.5 Shire Recent Developments/Updates
7.10.6 Shire Competitive Strengths & Weaknesses
7.11 Chengdu Rongsheng Pharmaceutical Co., Ltd
7.11.1 Chengdu Rongsheng Pharmaceutical Co., Ltd Details
7.11.2 Chengdu Rongsheng Pharmaceutical Co., Ltd Major Business
7.11.3 Chengdu Rongsheng Pharmaceutical Co., Ltd Primary Immunodeficiency Drugs Product and Services
7.11.4 Chengdu Rongsheng Pharmaceutical Co., Ltd Primary Immunodeficiency Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.11.5 Chengdu Rongsheng Pharmaceutical Co., Ltd Recent Developments/Updates
7.11.6 Chengdu Rongsheng Pharmaceutical Co., Ltd Competitive Strengths & Weaknesses
8 RAW MATERIAL AND INDUSTRY CHAIN
8.1 Raw Material of Primary Immunodeficiency Drugs and Key Manufacturers
8.2 Primary Immunodeficiency Drugs Manufacturing Costs
8.3 Primary Immunodeficiency Drugs Production Process
8.4 Primary Immunodeficiency Drugs Industrial Chain
9 DISTRIBUTION CHANNEL ANALYSIS
9.1 Distribution Channel Breakdown for Primary Immunodeficiency Drugs Shipments (%): 2017-2028
9.1.1 Direct Channel
9.1.2 Indirect Channel
9.2 Primary Immunodeficiency Drugs Typical Distributors
9.3 Primary Immunodeficiency Drugs Typical Customers
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
LIST OF TABLES
Table 1. World Primary Immunodeficiency Drugs Production Value by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Primary Immunodeficiency Drugs Production Value by Region (2017-2022) & (USD Million)
Table 3. World Primary Immunodeficiency Drugs Production Value by Region (2023-2028) & (USD Million)
Table 4. World Primary Immunodeficiency Drugs Production Value Market Share by Region (2017-2022)
Table 5. World Primary Immunodeficiency Drugs Production Value Market Share by Region (2023-2028)
Table 6. World Primary Immunodeficiency Drugs Production by Region (2017-2022) & (K Units)
Table 7. World Primary Immunodeficiency Drugs Production by Region (2023-2028) & (K Units)
Table 8. World Primary Immunodeficiency Drugs Production Market Share by Region (2017-2022)
Table 9. World Primary Immunodeficiency Drugs Production Market Share by Region (2023-2028)
Table 10. World Primary Immunodeficiency Drugs Average Price by Region (2017-2022) & (US$/Unit)
Table 11. World Primary Immunodeficiency Drugs Average Price by Region (2023-2028) & (US$/Unit)
Table 12. Primary Immunodeficiency Drugs Major Market Trends
Table 13. World Primary Immunodeficiency Drugs Consumption Growth Rate Forecast by Region (2017 & 2021 & 2028) & (K Units)
Table 14. World Primary Immunodeficiency Drugs Consumption by Region (2017-2022) & (K Units)
Table 15. World Primary Immunodeficiency Drugs Consumption Forecast by Region (2023-2028) & (K Units)
Table 16. World Primary Immunodeficiency Drugs Production Value by Manufacturer (2017-2022) & (USD Million)
Table 17. Production Value Market Share of Key Primary Immunodeficiency Drugs Producers in 2021
Table 18. World Primary Immunodeficiency Drugs Production by Manufacturer (2017-2022) & (K Units)
Table 19. Production Market Share of Key Primary Immunodeficiency Drugs Producers in 2021
Table 20. World Primary Immunodeficiency Drugs Average Price by Manufacturer (2017-2022) & (US$/Unit)
Table 21. Global Primary Immunodeficiency Drugs Company Evaluation Quadrant
Table 22. World Primary Immunodeficiency Drugs Industry Rank of Major Manufacturers, Based on Production Value in 2021
Table 23. Head Office and Primary Immunodeficiency Drugs Production Site of Key Manufacturer
Table 24. Primary Immunodeficiency Drugs Market: Company Product Type Footprint
Table 25. Primary Immunodeficiency Drugs Market: Company Product Application Footprint
Table 26. Primary Immunodeficiency Drugs Competitive Factors
Table 27. Primary Immunodeficiency Drugs New Entrant and Capacity Expansion Plans
Table 28. Primary Immunodeficiency Drugs Mergers & Acquisitions Activity
Table 29. United States VS China Primary Immunodeficiency Drugs Production Value Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 30. United States VS China Primary Immunodeficiency Drugs Production Comparison, (2017 & 2021 & 2028) & (K Units)
Table 31. United States VS China Primary Immunodeficiency Drugs Consumption Comparison, (2017 & 2021 & 2028) & (K Units)
Table 32. Major Manufacturer of Primary Immunodeficiency Drugs in United States, Company Headquarters and Production Place (States, Country)
Table 33. United States Primary Immunodeficiency Drugs Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 34. United States Primary Immunodeficiency Drugs Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 35. United States Primary Immunodeficiency Drugs Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 36. United States Primary Immunodeficiency Drugs Production Market Share by Domestic Manufacturer, (2017-2022)
Table 37. Major Manufacturer of Primary Immunodeficiency Drugs in China, Company Headquarters and Production Place (Province, Country)
Table 38. China Primary Immunodeficiency Drugs Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 39. China Primary Immunodeficiency Drugs Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 40. China Primary Immunodeficiency Drugs Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 41. China Primary Immunodeficiency Drugs Production Market Share by Domestic Manufacturer, (2017-2022)
Table 42. Major Manufacturer of Primary Immunodeficiency Drugs in Rest of World, Company Headquarters and Production Place (State, Country)
Table 43. Rest of World Primary Immunodeficiency Drugs Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 44. Rest of World Primary Immunodeficiency Drugs Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 45. Rest of World Primary Immunodeficiency Drugs Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 46. Rest of World Primary Immunodeficiency Drugs Production Market Share by Domestic Manufacturer, (2017-2022)
Table 47. World Primary Immunodeficiency Drugs Production Value by Type, (USD Million), 2017 & 2021 & 2028
Table 48. World Primary Immunodeficiency Drugs Production by Type (2017-2022) & (K Units)
Table 49. World Primary Immunodeficiency Drugs Production by Type (2023-2028) & (K Units)
Table 50. World Primary Immunodeficiency Drugs Production Value by Type (2017-2022) & (USD Million)
Table 51. World Primary Immunodeficiency Drugs Production Value by Type (2023-2028) & (USD Million)
Table 52. World Primary Immunodeficiency Drugs Average Price by Type (2017-2022) & (US$/Unit)
Table 53. World Primary Immunodeficiency Drugs Average Price by Type (2023-2028) & (US$/Unit)
Table 54. World Primary Immunodeficiency Drugs Production Value by Application, (USD Million), 2017 & 2021 & 2028
Table 55. World Primary Immunodeficiency Drugs Production by Application (2017-2022) & (K Units)
Table 56. World Primary Immunodeficiency Drugs Production by Application (2023-2028) & (K Units)
Table 57. World Primary Immunodeficiency Drugs Production Value by Application (2017-2022) & (USD Million)
Table 58. World Primary Immunodeficiency Drugs Production Value by Application (2023-2028) & (USD Million)
Table 59. World Primary Immunodeficiency Drugs Average Price by Application (2017-2022) & (US$/Unit)
Table 60. World Primary Immunodeficiency Drugs Average Price by Application (2023-2028) & (US$/Unit)
Table 61. ADMA Biologics, Inc. Basic Information, Manufacturing Base and Competitors
Table 62. ADMA Biologics, Inc. Major Business
Table 63. ADMA Biologics, Inc. Primary Immunodeficiency Drugs Product and Services
Table 64. ADMA Biologics, Inc. Primary Immunodeficiency Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 65. ADMA Biologics, Inc. Recent Developments/Updates
Table 66. ADMA Biologics, Inc. Competitive Strengths & Weaknesses
Table 67. CSL Behring, LLC Basic Information, Manufacturing Base and Competitors
Table 68. CSL Behring, LLC Major Business
Table 69. CSL Behring, LLC Primary Immunodeficiency Drugs Product and Services
Table 70. CSL Behring, LLC Primary Immunodeficiency Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 71. CSL Behring, LLC Recent Developments/Updates
Table 72. CSL Behring, LLC Competitive Strengths & Weaknesses
Table 73. Octapharma Basic Information, Manufacturing Base and Competitors
Table 74. Octapharma Major Business
Table 75. Octapharma Primary Immunodeficiency Drugs Product and Services
Table 76. Octapharma Primary Immunodeficiency Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 77. Octapharma Recent Developments/Updates
Table 78. Octapharma Competitive Strengths & Weaknesses
Table 79. Takeda Pharmaceutical Company Basic Information, Manufacturing Base and Competitors
Table 80. Takeda Pharmaceutical Company Major Business
Table 81. Takeda Pharmaceutical Company Primary Immunodeficiency Drugs Product and Services
Table 82. Takeda Pharmaceutical Company Primary Immunodeficiency Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 83. Takeda Pharmaceutical Company Recent Developments/Updates
Table 84. Takeda Pharmaceutical Company Competitive Strengths & Weaknesses
Table 85. Grifols Biologicals, Inc. Basic Information, Manufacturing Base and Competitors
Table 86. Grifols Biologicals, Inc. Major Business
Table 87. Grifols Biologicals, Inc. Primary Immunodeficiency Drugs Product and Services
Table 88. Grifols Biologicals, Inc. Primary Immunodeficiency Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 89. Grifols Biologicals, Inc. Recent Developments/Updates
Table 90. Grifols Biologicals, Inc. Competitive Strengths & Weaknesses
Table 91. Baxter Basic Information, Manufacturing Base and Competitors
Table 92. Baxter Major Business
Table 93. Baxter Primary Immunodeficiency Drugs Product and Services
Table 94. Baxter Primary Immunodeficiency Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 95. Baxter Recent Developments/Updates
Table 96. Baxter Competitive Strengths & Weaknesses
Table 97. Kedrion Biopharma Basic Information, Manufacturing Base and Competitors
Table 98. Kedrion Biopharma Major Business
Table 99. Kedrion Biopharma Primary Immunodeficiency Drugs Product and Services
Table 100. Kedrion Biopharma Primary Immunodeficiency Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 101. Kedrion Biopharma Recent Developments/Updates
Table 102. Kedrion Biopharma Competitive Strengths & Weaknesses
Table 103. BPL Inc. Basic Information, Manufacturing Base and Competitors
Table 104. BPL Inc. Major Business
Table 105. BPL Inc. Primary Immunodeficiency Drugs Product and Services
Table 106. BPL Inc. Primary Immunodeficiency Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 107. BPL Inc. Recent Developments/Updates
Table 108. BPL Inc. Competitive Strengths & Weaknesses
Table 109. Pharming Group Basic Information, Manufacturing Base and Competitors
Table 110. Pharming Group Major Business
Table 111. Pharming Group Primary Immunodeficiency Drugs Product and Services
Table 112. Pharming Group Primary Immunodeficiency Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 113. Pharming Group Recent Developments/Updates
Table 114. Pharming Group Competitive Strengths & Weaknesses
Table 115. Shire Basic Information, Manufacturing Base and Competitors
Table 116. Shire Major Business
Table 117. Shire Primary Immunodeficiency Drugs Product and Services
Table 118. Shire Primary Immunodeficiency Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 119. Shire Recent Developments/Updates
Table 120. Chengdu Rongsheng Pharmaceutical Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 121. Chengdu Rongsheng Pharmaceutical Co., Ltd Major Business
Table 122. Chengdu Rongsheng Pharmaceutical Co., Ltd Primary Immunodeficiency Drugs Product and Services
Table 123. Chengdu Rongsheng Pharmaceutical Co., Ltd Primary Immunodeficiency Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 124. Primary Immunodeficiency Drugs Raw Material
Table 125. Key Manufacturers of Primary Immunodeficiency Drugs Raw Materials
Table 126. Primary Immunodeficiency Drugs Typical Distributors
Table 127. Primary Immunodeficiency Drugs Typical Customers
Table 1. World Primary Immunodeficiency Drugs Production Value by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Primary Immunodeficiency Drugs Production Value by Region (2017-2022) & (USD Million)
Table 3. World Primary Immunodeficiency Drugs Production Value by Region (2023-2028) & (USD Million)
Table 4. World Primary Immunodeficiency Drugs Production Value Market Share by Region (2017-2022)
Table 5. World Primary Immunodeficiency Drugs Production Value Market Share by Region (2023-2028)
Table 6. World Primary Immunodeficiency Drugs Production by Region (2017-2022) & (K Units)
Table 7. World Primary Immunodeficiency Drugs Production by Region (2023-2028) & (K Units)
Table 8. World Primary Immunodeficiency Drugs Production Market Share by Region (2017-2022)
Table 9. World Primary Immunodeficiency Drugs Production Market Share by Region (2023-2028)
Table 10. World Primary Immunodeficiency Drugs Average Price by Region (2017-2022) & (US$/Unit)
Table 11. World Primary Immunodeficiency Drugs Average Price by Region (2023-2028) & (US$/Unit)
Table 12. Primary Immunodeficiency Drugs Major Market Trends
Table 13. World Primary Immunodeficiency Drugs Consumption Growth Rate Forecast by Region (2017 & 2021 & 2028) & (K Units)
Table 14. World Primary Immunodeficiency Drugs Consumption by Region (2017-2022) & (K Units)
Table 15. World Primary Immunodeficiency Drugs Consumption Forecast by Region (2023-2028) & (K Units)
Table 16. World Primary Immunodeficiency Drugs Production Value by Manufacturer (2017-2022) & (USD Million)
Table 17. Production Value Market Share of Key Primary Immunodeficiency Drugs Producers in 2021
Table 18. World Primary Immunodeficiency Drugs Production by Manufacturer (2017-2022) & (K Units)
Table 19. Production Market Share of Key Primary Immunodeficiency Drugs Producers in 2021
Table 20. World Primary Immunodeficiency Drugs Average Price by Manufacturer (2017-2022) & (US$/Unit)
Table 21. Global Primary Immunodeficiency Drugs Company Evaluation Quadrant
Table 22. World Primary Immunodeficiency Drugs Industry Rank of Major Manufacturers, Based on Production Value in 2021
Table 23. Head Office and Primary Immunodeficiency Drugs Production Site of Key Manufacturer
Table 24. Primary Immunodeficiency Drugs Market: Company Product Type Footprint
Table 25. Primary Immunodeficiency Drugs Market: Company Product Application Footprint
Table 26. Primary Immunodeficiency Drugs Competitive Factors
Table 27. Primary Immunodeficiency Drugs New Entrant and Capacity Expansion Plans
Table 28. Primary Immunodeficiency Drugs Mergers & Acquisitions Activity
Table 29. United States VS China Primary Immunodeficiency Drugs Production Value Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 30. United States VS China Primary Immunodeficiency Drugs Production Comparison, (2017 & 2021 & 2028) & (K Units)
Table 31. United States VS China Primary Immunodeficiency Drugs Consumption Comparison, (2017 & 2021 & 2028) & (K Units)
Table 32. Major Manufacturer of Primary Immunodeficiency Drugs in United States, Company Headquarters and Production Place (States, Country)
Table 33. United States Primary Immunodeficiency Drugs Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 34. United States Primary Immunodeficiency Drugs Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 35. United States Primary Immunodeficiency Drugs Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 36. United States Primary Immunodeficiency Drugs Production Market Share by Domestic Manufacturer, (2017-2022)
Table 37. Major Manufacturer of Primary Immunodeficiency Drugs in China, Company Headquarters and Production Place (Province, Country)
Table 38. China Primary Immunodeficiency Drugs Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 39. China Primary Immunodeficiency Drugs Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 40. China Primary Immunodeficiency Drugs Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 41. China Primary Immunodeficiency Drugs Production Market Share by Domestic Manufacturer, (2017-2022)
Table 42. Major Manufacturer of Primary Immunodeficiency Drugs in Rest of World, Company Headquarters and Production Place (State, Country)
Table 43. Rest of World Primary Immunodeficiency Drugs Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 44. Rest of World Primary Immunodeficiency Drugs Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 45. Rest of World Primary Immunodeficiency Drugs Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 46. Rest of World Primary Immunodeficiency Drugs Production Market Share by Domestic Manufacturer, (2017-2022)
Table 47. World Primary Immunodeficiency Drugs Production Value by Type, (USD Million), 2017 & 2021 & 2028
Table 48. World Primary Immunodeficiency Drugs Production by Type (2017-2022) & (K Units)
Table 49. World Primary Immunodeficiency Drugs Production by Type (2023-2028) & (K Units)
Table 50. World Primary Immunodeficiency Drugs Production Value by Type (2017-2022) & (USD Million)
Table 51. World Primary Immunodeficiency Drugs Production Value by Type (2023-2028) & (USD Million)
Table 52. World Primary Immunodeficiency Drugs Average Price by Type (2017-2022) & (US$/Unit)
Table 53. World Primary Immunodeficiency Drugs Average Price by Type (2023-2028) & (US$/Unit)
Table 54. World Primary Immunodeficiency Drugs Production Value by Application, (USD Million), 2017 & 2021 & 2028
Table 55. World Primary Immunodeficiency Drugs Production by Application (2017-2022) & (K Units)
Table 56. World Primary Immunodeficiency Drugs Production by Application (2023-2028) & (K Units)
Table 57. World Primary Immunodeficiency Drugs Production Value by Application (2017-2022) & (USD Million)
Table 58. World Primary Immunodeficiency Drugs Production Value by Application (2023-2028) & (USD Million)
Table 59. World Primary Immunodeficiency Drugs Average Price by Application (2017-2022) & (US$/Unit)
Table 60. World Primary Immunodeficiency Drugs Average Price by Application (2023-2028) & (US$/Unit)
Table 61. ADMA Biologics, Inc. Basic Information, Manufacturing Base and Competitors
Table 62. ADMA Biologics, Inc. Major Business
Table 63. ADMA Biologics, Inc. Primary Immunodeficiency Drugs Product and Services
Table 64. ADMA Biologics, Inc. Primary Immunodeficiency Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 65. ADMA Biologics, Inc. Recent Developments/Updates
Table 66. ADMA Biologics, Inc. Competitive Strengths & Weaknesses
Table 67. CSL Behring, LLC Basic Information, Manufacturing Base and Competitors
Table 68. CSL Behring, LLC Major Business
Table 69. CSL Behring, LLC Primary Immunodeficiency Drugs Product and Services
Table 70. CSL Behring, LLC Primary Immunodeficiency Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 71. CSL Behring, LLC Recent Developments/Updates
Table 72. CSL Behring, LLC Competitive Strengths & Weaknesses
Table 73. Octapharma Basic Information, Manufacturing Base and Competitors
Table 74. Octapharma Major Business
Table 75. Octapharma Primary Immunodeficiency Drugs Product and Services
Table 76. Octapharma Primary Immunodeficiency Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 77. Octapharma Recent Developments/Updates
Table 78. Octapharma Competitive Strengths & Weaknesses
Table 79. Takeda Pharmaceutical Company Basic Information, Manufacturing Base and Competitors
Table 80. Takeda Pharmaceutical Company Major Business
Table 81. Takeda Pharmaceutical Company Primary Immunodeficiency Drugs Product and Services
Table 82. Takeda Pharmaceutical Company Primary Immunodeficiency Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 83. Takeda Pharmaceutical Company Recent Developments/Updates
Table 84. Takeda Pharmaceutical Company Competitive Strengths & Weaknesses
Table 85. Grifols Biologicals, Inc. Basic Information, Manufacturing Base and Competitors
Table 86. Grifols Biologicals, Inc. Major Business
Table 87. Grifols Biologicals, Inc. Primary Immunodeficiency Drugs Product and Services
Table 88. Grifols Biologicals, Inc. Primary Immunodeficiency Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 89. Grifols Biologicals, Inc. Recent Developments/Updates
Table 90. Grifols Biologicals, Inc. Competitive Strengths & Weaknesses
Table 91. Baxter Basic Information, Manufacturing Base and Competitors
Table 92. Baxter Major Business
Table 93. Baxter Primary Immunodeficiency Drugs Product and Services
Table 94. Baxter Primary Immunodeficiency Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 95. Baxter Recent Developments/Updates
Table 96. Baxter Competitive Strengths & Weaknesses
Table 97. Kedrion Biopharma Basic Information, Manufacturing Base and Competitors
Table 98. Kedrion Biopharma Major Business
Table 99. Kedrion Biopharma Primary Immunodeficiency Drugs Product and Services
Table 100. Kedrion Biopharma Primary Immunodeficiency Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 101. Kedrion Biopharma Recent Developments/Updates
Table 102. Kedrion Biopharma Competitive Strengths & Weaknesses
Table 103. BPL Inc. Basic Information, Manufacturing Base and Competitors
Table 104. BPL Inc. Major Business
Table 105. BPL Inc. Primary Immunodeficiency Drugs Product and Services
Table 106. BPL Inc. Primary Immunodeficiency Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 107. BPL Inc. Recent Developments/Updates
Table 108. BPL Inc. Competitive Strengths & Weaknesses
Table 109. Pharming Group Basic Information, Manufacturing Base and Competitors
Table 110. Pharming Group Major Business
Table 111. Pharming Group Primary Immunodeficiency Drugs Product and Services
Table 112. Pharming Group Primary Immunodeficiency Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 113. Pharming Group Recent Developments/Updates
Table 114. Pharming Group Competitive Strengths & Weaknesses
Table 115. Shire Basic Information, Manufacturing Base and Competitors
Table 116. Shire Major Business
Table 117. Shire Primary Immunodeficiency Drugs Product and Services
Table 118. Shire Primary Immunodeficiency Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 119. Shire Recent Developments/Updates
Table 120. Chengdu Rongsheng Pharmaceutical Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 121. Chengdu Rongsheng Pharmaceutical Co., Ltd Major Business
Table 122. Chengdu Rongsheng Pharmaceutical Co., Ltd Primary Immunodeficiency Drugs Product and Services
Table 123. Chengdu Rongsheng Pharmaceutical Co., Ltd Primary Immunodeficiency Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 124. Primary Immunodeficiency Drugs Raw Material
Table 125. Key Manufacturers of Primary Immunodeficiency Drugs Raw Materials
Table 126. Primary Immunodeficiency Drugs Typical Distributors
Table 127. Primary Immunodeficiency Drugs Typical Customers
LIST OF FIGURES
Figure 1. Primary Immunodeficiency Drugs Picture
Figure 2. World Primary Immunodeficiency Drugs Production Value: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Primary Immunodeficiency Drugs Production Value and Forecast (2017-2028) & (USD Million)
Figure 4. World Primary Immunodeficiency Drugs Production (2017-2028) & (K Units)
Figure 5. World Primary Immunodeficiency Drugs Average Price (2017-2028) & (US$/Unit)
Figure 6. World Primary Immunodeficiency Drugs Production Value Market Share by Region (2017-2028)
Figure 7. World Primary Immunodeficiency Drugs Production Market Share by Region (2017-2028)
Figure 8. North America Primary Immunodeficiency Drugs Production (2017-2028) & (K Units)
Figure 9. Europe Primary Immunodeficiency Drugs Production (2017-2028) & (K Units)
Figure 10. China Primary Immunodeficiency Drugs Production (2017-2028) & (K Units)
Figure 11. Japan Primary Immunodeficiency Drugs Production (2017-2028) & (K Units)
Figure 12. Primary Immunodeficiency Drugs Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Primary Immunodeficiency Drugs Demand (2017-2028) & (K Units)
Figure 15. World Primary Immunodeficiency Drugs Consumption Market Share by Region (2017-2028)
Figure 16. United States Primary Immunodeficiency Drugs Consumption (2017-2028) & (K Units)
Figure 17. China Primary Immunodeficiency Drugs Consumption (2017-2028) & (K Units)
Figure 18. Europe Primary Immunodeficiency Drugs Consumption (2017-2028) & (K Units)
Figure 19. Japan Primary Immunodeficiency Drugs Consumption (2017-2028) & (K Units)
Figure 20. South Korea Primary Immunodeficiency Drugs Consumption (2017-2028) & (K Units)
Figure 21. ASEAN Primary Immunodeficiency Drugs Consumption (2017-2028) & (K Units)
Figure 22. India Primary Immunodeficiency Drugs Consumption (2017-2028) & (K Units)
Figure 23. Producer Shipments of Primary Immunodeficiency Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2021
Figure 24. Global Four-firm Concentration Ratios (CR4) for Primary Immunodeficiency Drugs Markets in 2021
Figure 25. Global Four-firm Concentration Ratios (CR8) for Primary Immunodeficiency Drugs Markets in 2021
Figure 26. United States VS China: Primary Immunodeficiency Drugs Production Value Market Share Comparison (2017 & 2021 & 2028)
Figure 27. United States VS China: Primary Immunodeficiency Drugs Production Market Share Comparison (2017 & 2021 & 2028)
Figure 28. United States VS China: Primary Immunodeficiency Drugs Consumption Market Share Comparison (2017 & 2021 & 2028)
Figure 29. Key Producers and Market Share of Primary Immunodeficiency Drugs in United States
Figure 30. Key Producers and Market Share of Primary Immunodeficiency Drugs in China
Figure 31. Key Producers and Market Share of Primary Immunodeficiency Drugs in Rest of World
Figure 32. World Primary Immunodeficiency Drugs Production Value by Type, (USD Million), 2017 & 2021 & 2028
Figure 33. World Primary Immunodeficiency Drugs Production Value Market Share by Type in 2021
Figure 34. Cytokines
Figure 35. Anti Cytokine Antibodies
Figure 36. Signal Molecule Inhibitor
Figure 37. World Primary Immunodeficiency Drugs Production Market Share by Type (2017-2028)
Figure 38. World Primary Immunodeficiency Drugs Production Value Market Share by Type (2017-2028)
Figure 39. World Primary Immunodeficiency Drugs Average Price by Type (2017-2028) & (US$/Unit)
Figure 40. World Primary Immunodeficiency Drugs Production Value by Application, (USD Million), 2017 & 2021 & 2028
Figure 41. World Primary Immunodeficiency Drugs Production Value Market Share by Application in 2021
Figure 42. Hospital
Figure 43. Specialist Clinic
Figure 44. Othere
Figure 45. World Primary Immunodeficiency Drugs Production Market Share by Application (2017-2028)
Figure 46. World Primary Immunodeficiency Drugs Production Value Market Share by Application (2017-2028)
Figure 47. World Primary Immunodeficiency Drugs Average Price by Application (2017-2028) & (US$/Unit)
Figure 48. Manufacturing Cost Structure Analysis of Primary Immunodeficiency Drugs in 2021
Figure 49. Manufacturing Process Analysis of Primary Immunodeficiency Drugs
Figure 50. Primary Immunodeficiency Drugs Industrial Chain
Figure 51. Distribution Channel Breakdown for Primary Immunodeficiency Drugs Shipments (%): 2017-2028
Figure 52. Direct Channel Pros & Cons
Figure 53. Indirect Channel Pros & Cons
Figure 54. Methodology
Figure 55. Research Process and Data Source
Figure 1. Primary Immunodeficiency Drugs Picture
Figure 2. World Primary Immunodeficiency Drugs Production Value: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Primary Immunodeficiency Drugs Production Value and Forecast (2017-2028) & (USD Million)
Figure 4. World Primary Immunodeficiency Drugs Production (2017-2028) & (K Units)
Figure 5. World Primary Immunodeficiency Drugs Average Price (2017-2028) & (US$/Unit)
Figure 6. World Primary Immunodeficiency Drugs Production Value Market Share by Region (2017-2028)
Figure 7. World Primary Immunodeficiency Drugs Production Market Share by Region (2017-2028)
Figure 8. North America Primary Immunodeficiency Drugs Production (2017-2028) & (K Units)
Figure 9. Europe Primary Immunodeficiency Drugs Production (2017-2028) & (K Units)
Figure 10. China Primary Immunodeficiency Drugs Production (2017-2028) & (K Units)
Figure 11. Japan Primary Immunodeficiency Drugs Production (2017-2028) & (K Units)
Figure 12. Primary Immunodeficiency Drugs Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Primary Immunodeficiency Drugs Demand (2017-2028) & (K Units)
Figure 15. World Primary Immunodeficiency Drugs Consumption Market Share by Region (2017-2028)
Figure 16. United States Primary Immunodeficiency Drugs Consumption (2017-2028) & (K Units)
Figure 17. China Primary Immunodeficiency Drugs Consumption (2017-2028) & (K Units)
Figure 18. Europe Primary Immunodeficiency Drugs Consumption (2017-2028) & (K Units)
Figure 19. Japan Primary Immunodeficiency Drugs Consumption (2017-2028) & (K Units)
Figure 20. South Korea Primary Immunodeficiency Drugs Consumption (2017-2028) & (K Units)
Figure 21. ASEAN Primary Immunodeficiency Drugs Consumption (2017-2028) & (K Units)
Figure 22. India Primary Immunodeficiency Drugs Consumption (2017-2028) & (K Units)
Figure 23. Producer Shipments of Primary Immunodeficiency Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2021
Figure 24. Global Four-firm Concentration Ratios (CR4) for Primary Immunodeficiency Drugs Markets in 2021
Figure 25. Global Four-firm Concentration Ratios (CR8) for Primary Immunodeficiency Drugs Markets in 2021
Figure 26. United States VS China: Primary Immunodeficiency Drugs Production Value Market Share Comparison (2017 & 2021 & 2028)
Figure 27. United States VS China: Primary Immunodeficiency Drugs Production Market Share Comparison (2017 & 2021 & 2028)
Figure 28. United States VS China: Primary Immunodeficiency Drugs Consumption Market Share Comparison (2017 & 2021 & 2028)
Figure 29. Key Producers and Market Share of Primary Immunodeficiency Drugs in United States
Figure 30. Key Producers and Market Share of Primary Immunodeficiency Drugs in China
Figure 31. Key Producers and Market Share of Primary Immunodeficiency Drugs in Rest of World
Figure 32. World Primary Immunodeficiency Drugs Production Value by Type, (USD Million), 2017 & 2021 & 2028
Figure 33. World Primary Immunodeficiency Drugs Production Value Market Share by Type in 2021
Figure 34. Cytokines
Figure 35. Anti Cytokine Antibodies
Figure 36. Signal Molecule Inhibitor
Figure 37. World Primary Immunodeficiency Drugs Production Market Share by Type (2017-2028)
Figure 38. World Primary Immunodeficiency Drugs Production Value Market Share by Type (2017-2028)
Figure 39. World Primary Immunodeficiency Drugs Average Price by Type (2017-2028) & (US$/Unit)
Figure 40. World Primary Immunodeficiency Drugs Production Value by Application, (USD Million), 2017 & 2021 & 2028
Figure 41. World Primary Immunodeficiency Drugs Production Value Market Share by Application in 2021
Figure 42. Hospital
Figure 43. Specialist Clinic
Figure 44. Othere
Figure 45. World Primary Immunodeficiency Drugs Production Market Share by Application (2017-2028)
Figure 46. World Primary Immunodeficiency Drugs Production Value Market Share by Application (2017-2028)
Figure 47. World Primary Immunodeficiency Drugs Average Price by Application (2017-2028) & (US$/Unit)
Figure 48. Manufacturing Cost Structure Analysis of Primary Immunodeficiency Drugs in 2021
Figure 49. Manufacturing Process Analysis of Primary Immunodeficiency Drugs
Figure 50. Primary Immunodeficiency Drugs Industrial Chain
Figure 51. Distribution Channel Breakdown for Primary Immunodeficiency Drugs Shipments (%): 2017-2028
Figure 52. Direct Channel Pros & Cons
Figure 53. Indirect Channel Pros & Cons
Figure 54. Methodology
Figure 55. Research Process and Data Source
